FOSUN HEALTH Logo

Chronic Kidney Disease Overview

catalogue

Chronic Kidney Disease Overview

Chronic Kidney Disease Overview

Chronic kidney disease is the long-term loss of kidney function, and its defining feature is that it is quiet: most people have no symptom at all until the disease is well advanced. That is why it is defined by measurement rather than by complaint — two numbers, one from the blood and one from the urine, taken three months apart. This guide follows the path patients actually take: what those two numbers mean, what is causing the damage, what genuinely slows it, and how dialysis and transplantation are planned rather than arrived at by surprise.

Chronic Kidney Disease Overview
  • define the disease — filtration rate and albumin in the urine

  • the year our nephrology department was established

  • haemodialysis machines, with 20 specialised beds and 2 CRRT machines

  • kidney outpatient visits a year, and close to 1,000 inpatient admissions

What chronic kidney disease is — and why it is defined by numbers, not symptoms

The kidneys filter the blood, and everything else they do follows from that: they balance water and salt, they hold the blood's chemistry within the narrow range cells can tolerate, they make the hormones that keep bones strong and blood circulating, and they clear the medicines the body has finished with. Chronic kidney disease is the long-term, usually progressive loss of that work.

It is defined by measurement rather than by how a person feels, because for most of its course it produces nothing to feel. A person can lose a substantial share of their filtering capacity and notice no change at all; by the time tiredness, swelling or nausea appear, the disease has usually been running for years. This is the single most important thing to understand about it, because it explains everything else: the diagnosis is made by a blood test and a urine test, the severity is expressed in categories rather than in adjectives, and progress is tracked as a slope on a chart rather than as a change in wellbeing.

The definition has two parts, and either one is enough. The first is a filtration rate — eGFR — that has been below 60 ml/min/1.73 m² for at least three months. The second is a marker of damage, most importantly albumin in the urine, even when the filtration rate is still normal. Both must be present on at least two occasions months apart, because a single abnormal reading can be a passing state rather than a chronic one.

One further distinction shapes every conversation that follows. Acute kidney injury happens over hours or days, often has a visible cause — an infection, a medicine, a blocked catheter, a bout of severe dehydration — and frequently recovers. Chronic kidney disease is measured over months and years. The two overlap: an acute injury laid on top of chronic disease is the commonest reason a stable patient suddenly deteriorates, and protecting against those episodes is part of managing the chronic one.

The causes behind the label, and why the cause decides the treatment

"Chronic kidney disease" is a description of function, not of cause — like "anaemia" or "heart failure". Six broad mechanisms produce it, and the label alone does not say which one is at work. Establishing the cause is not an academic exercise: immune diseases are treated with immune suppression, obstruction is treated by relieving it, diabetic kidney disease is treated with the medicines that also protect the heart, and a medicine that is quietly injuring the kidneys is stopped. Treating the number without treating the cause is how years pass with a stable chart and a progressive disease.

Cause What is happening How it usually presents What it means for treatment
Diabetes Years of high glucose damage the filtering units' small vessels and the membrane that holds protein back Albumin appearing in the urine, then a slow fall in filtration rate; often no symptom at all Glucose control plus the medicines that protect the kidney independently of glucose — blood pressure agents and SGLT2 inhibitors
High blood pressure Sustained pressure damages the same small vessels the kidney depends on, and the kidney's own pressure regulation is lost in a loop Long-standing hypertension, often with modest protein leak; the two conditions worsen each other Pressure treated to target, usually with agents that also lower pressure inside the filtering unit
Glomerular and immune disease The immune system attacks the filtering units themselves — IgA nephropathy, lupus nephritis and their relatives Blood and protein in the urine, sometimes after an infection; can fall quickly and can present younger Immune suppression where the pattern and the risk justify it; this is where biopsy most often changes the plan
Cystic and inherited disease Cysts replace working tissue over decades — polycystic kidney disease being the commonest A strong family history, enlarged kidneys on imaging, hypertension appearing early No disease-modifying treatment for the cysts themselves; the work is blood pressure, complications and planning
Obstruction and reflux Urine cannot drain freely — stones, an enlarged prostate, a narrowed junction — and pressure backs up into the kidney Flank pain or recurrent infection; often silent until function has already fallen Relieve the obstruction; this is one of the few causes where function can improve after treatment
Unknown or multiple No single cause found, or several acting together — commoner than most patients expect, particularly when the disease is already advanced Late presentation with small, scarred kidneys, where the original cause has left no fingerprint Treatment aimed at what is measurable: pressure, albuminuria, complications, and protection from further injury

Notice the pattern in the last column. The cause decides the treatment, and in one row above the treatment is a procedure rather than a medicine. That is why finding the cause is written into the assessment rather than treated as an optional extra.

The two numbers that stage it: filtration rate and albumin

Staging is not one scale but two read together, because they carry partly independent information. The first, G, is how much filtering capacity remains. The second, A, is how much protein is leaking — which predicts both how fast function will fall and how much cardiovascular risk is attached. A person with a normal filtration rate and heavy protein leak is not in the same position as a person with the same filtration rate and none, and the staging says so.

Category What the test shows What it means in practice
G1–G2 Filtration rate 60 or above — normal or near-normal Not chronic kidney disease on this number alone; it becomes CKD when a marker of damage such as albuminuria is present
G3a Filtration rate 45–59 Mild-to-moderate reduction. Complications begin to appear here — blood pressure, bone chemistry, anaemia — and monitoring becomes structured
G3b Filtration rate 30–44 Moderate-to-severe reduction. Referral to a kidney specialist is expected, and planning for the future starts while the person feels well
G4 Filtration rate 15–29 Severe reduction. Preparation for kidney replacement — education, access planning, transplant assessment — is the work of this stage, undertaken early rather than late
G5 Filtration rate below 15, or on dialysis Kidney failure. Dialysis or transplantation is needed; the question is which, and on whose timetable

The albumin axis runs from A1, where the urine is normal or near-normal, through A2 — a moderate increase that already signals higher risk — to A3, a heavy leak that accelerates loss of function and carries the greatest cardiovascular risk. The two axes are written together: G3b A3 and G3b A1 are the same filtration rate and different diseases.

Two consequences follow from reading staging this way. First, the number that most repays attention is the trend rather than the value: a filtration rate of 52 that has been 88, 70 and 52 over three years is a more urgent finding than a stable 52 of a decade's standing. Second, staging is what makes a written plan transferable — a team in another country can read "G3b A3, falling by about 5 a year" and know exactly where a patient stands.

What a full kidney assessment actually contains

The assessment is mostly blood and urine, and it is arranged so that each test answers one question. Very little of it is exotic. The failure mode is not that the tests are unavailable; it is that only some of them were done, and a conclusion was drawn from half a picture.

Test What it measures What it answers
eGFR from creatinine Filtering capacity, estimated from a blood measurement that is cheap, standardised and widely available How much function remains — the G of the staging. Read as a trend, never as an isolated value
Urine albumin-to-creatinine ratio The leak of protein into urine, corrected for how concentrated the sample is The A of the staging, and the strongest single predictor of how fast function will be lost
Blood pressure, including home readings The pressure the kidney's vessels are being asked to withstand, outside the consulting room Both a cause and an accelerator; the number that most treatments are aimed at
Kidney ultrasound Size, shape, scarring, and whether urine is draining freely Whether the disease looks chronic — small, scarred kidneys — and whether obstruction is present, which is one of the reversible causes
Blood chemistry panel Haemoglobin, calcium, phosphate, parathyroid hormone, bicarbonate, potassium and the rest Which complications have already begun, so they can be treated rather than waited for
Kidney biopsy A small sample of kidney tissue read under several kinds of microscope What the disease actually is, where the answer would change the treatment. Not needed for every patient; decisive for some

Immune and metabolic blood tests — antibodies, complement, protein electrophoresis, HbA1c — are drawn in the same pass, because they are the difference between a label and a mechanism. The diagnosis page sets out what each is for and where a biopsy genuinely changes the plan.

Why patients travel to China for chronic kidney disease

Our nephrology department was established in 2004 and is the leading unit of the Fosun Health Nephrology Specialty Alliance, led by Associate Professor Liu Xiaogang. It runs an outpatient clinic, inpatient wards and a haemodialysis unit with 20 specialised beds, more than 30 haemodialysis machines and 2 CRRT machines, and handles nearly 20,000 kidney outpatient visits and close to 1,000 inpatient admissions a year.

The equipment matters to a specific group of patients: Fresenius haemodialysis machines, haemodiafiltration machines and CRRT, a secondary reverse osmosis water treatment system, a haemodialysis information management system and a centralised fluid supply system. So does the range of work the department does under one roof — primary and secondary kidney disease including IgA nephropathy, diabetic kidney disease and lupus nephritis; hyperuricaemia, gout and urate nephropathy; comprehensive chronic kidney disease management; peritoneal dialysis catheter placement; vascular access establishment and maintenance; and double plasma exchange and hybrid blood purification.

What patients mostly travel for, though, is not a machine but an answer. A large share of the international enquiries we receive come from people whose condition has been monitored but never explained: a filtration rate that has been falling for years with no cause ever established, proteinuria that nobody has investigated, or a biopsy that was never offered. The assessment described on the diagnosis page is built around closing that gap, and it is performed from records before any travel is discussed.

For patients who are already on dialysis, travel is a different and more practical question, and it is answered on the practical questions page: whether a dialysis schedule can be arranged here, what records are needed, and how treatment continues after the patient goes home.

Next in this guide: for what the disease does and does not feel like, read the symptoms and why it is silent; for what actually slows it, read treatment.

Frequently Asked Questions

Does chronic kidney disease always get worse?

No, and this is the point patients most often miss. Many people live for years, and some for the rest of their lives, at a stable stage — particularly where the cause is treated and blood pressure, glucose and albuminuria are controlled. What is true is that function already lost does not come back, and that the rate of loss varies enormously between people. The aim of treatment is to move a patient onto the slower of those paths and to keep them there.

Can chronic kidney disease be cured?

Not in the sense of restoring kidneys that have already scarred. Acute kidney injury can recover, and a few specific causes — obstruction, some immune diseases caught early, a drug that has been stopped — can improve substantially when treated. But established chronic kidney disease is managed rather than cured: the realistic goals are a slower slope, fewer complications, and a planned rather than a forced transition to dialysis or transplantation if function does reach that point.

How long can someone live with chronic kidney disease?

Long — and for most people the greater risk is cardiovascular rather than the kidneys themselves. People with chronic kidney disease are more likely to die of heart disease and stroke than to reach dialysis, which is why blood pressure, cholesterol, smoking and glucose are treated as seriously as the kidney numbers. Expected survival depends on stage, age and the other conditions a person carries, and it is a fair question to put to the treating team with the actual numbers in front of them.

Is it worth travelling for a second opinion on kidney disease?

It can be, particularly where the cause has never been established. Two questions decide most of the value: what is actually causing this, and does that answer change the treatment. Where diabetes and hypertension are the obvious cause and both are already well managed, a second opinion changes little. Where proteinuria is heavy, where function is falling faster than expected, or where an immune cause is possible, establishing the cause by blood tests, imaging or biopsy can change the treatment materially — and that is the assessment our team performs from records before any travel is discussed.

Find out what is actually causing it

Send the kidney blood tests you already have — creatinine and eGFR over as long a period as possible — the most recent urine albumin-to-creatinine ratio, any imaging reports, your blood pressure readings and your current medicines including over-the-counter painkillers. Our team will return a written opinion on the stage, the likely cause, and which of the missing tests would change the treatment, before any travel is arranged.

Want to see the whole process first? Your full medical journey, step by step →

Book an Appointment Request a Video Consultation

Follow Fosun Health

Apply for an Appointment

Do you have test results*